Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis

被引：0
|
作者：
Mitsani, D. [1 ]
Nguyen, H. [1 ]
Shields, R. [1 ]
Toyoda, Y. [1 ]
Bhama, J. [1 ]
Kwak, E. [1 ]
Silveira, F. [1 ]
Pilewski, J. [1 ]
Crespo, M. [1 ]
Clancy, C. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2011年 / 30卷 / 04期
关键词：
D O I：
10.1016/j.healun.2011.01.112
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
105
引用
收藏
页码：S42 / S43
页数：2
相关论文
共 50 条
  • [1] Therapeutic Drug Monitoring in Lung Transplant Recipients Receiving Itraconazole Prophylaxis
    Chong, P.
    Hathcock, M.
    Kremers, W.
    Kennedy, C.
    Razonable, R.
    TRANSPLANTATION, 2014, 98 : 806 - 806
  • [2] Voriconazole therapeutic drug monitoring among lung transplant recipients receiving targeted therapy for invasive aspergillosis
    Butler-Laporte, Guillaume
    Langevin, Marie-Claude
    Lemieux, Claude
    Poirier, Charles
    Ferraro, Pasquale
    Theoret, Yves
    Me-Linh Luong
    CLINICAL TRANSPLANTATION, 2022, 36 (08)
  • [3] Voriconazole Therapeutic Drug Monitoring Among Lung Transplant Recipients Receiving Targeted Therapy for Invasive Aspergillosis
    Butler-Laporte, G.
    Poirier, C.
    Ferraro, P.
    Langevin, M.
    Lemieux, C.
    Theoret, Y.
    Luong, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S240 - S240
  • [4] Therapeutic Drug Monitoring in Lung Transplant Recipients Receiving Itraconazole Prophylaxis.
    Chong, P.
    Hathcock, M.
    Kremers, W.
    Kennedy, C.
    Razonable, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 806 - 806
  • [5] Voriconazole prophylaxis in lung transplant recipients
    Husain, S.
    Paterson, D. L.
    Studer, S.
    Pilewski, J.
    Crespo, M.
    Zaldonis, D.
    Shutt, K.
    Pakstis, D. L.
    Zeevi, A.
    Johnson, B.
    Kwak, E. J.
    McCurry, K. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (12) : 3008 - 3016
  • [6] Efficacy and Safety of Voriconazole Prophylaxis among Lung Transplant Recipients
    Kwak, E. J.
    Husain, S.
    Silveira, F.
    Toyoda, Y.
    Pilewski, J.
    Crespo, M.
    Bermudez, C.
    Clancy, C.
    Nguyen, M. H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 390 - 390
  • [7] Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
    Mitsani, Dimitra
    Nguyen, M. Hong
    Shields, Ryan K.
    Toyoda, Yoshiya
    Kwak, Eun J.
    Silveira, Fernanda P.
    Pilewski, Joseph M.
    Crespo, Maria M.
    Bermudez, Christian
    Bhama, Jay K.
    Clancy, Cornelius J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (05) : 2371 - 2377
  • [8] Abscence of zygomyces infection in lung transplant recipients receiving voriconazole prophylaxis.
    Husain, S
    Zaldonis, DB
    Studer, S
    McCurry, KR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 354 - 354
  • [9] Therapeutic drug monitoring in lung transplant recipients receiving concomitant posaconazole and tacrolimus
    Quaranta, S.
    Reynaud-Gaubert, M.
    Solas, C.
    Bontface, S.
    Lacarelle, B.
    Sampol-Manos, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 26 - 27
  • [10] Voriconazole Associated Adverse Drug Events and Drug Monitoring in Lung Transplant Recipients
    Luo, C. Y.
    Nador, R. G.
    Levy, R. D.
    Yee, J.
    Wei, L.
    Partovi, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1128 - 1128
12345